It is possible that PRMT1 circRNA transcripts are preferentially produced in distinct subtypes of breast cancer, while aberrant alternative splicing of PRMT1 circRNAs may act as a driver for breast cancer tumorigenesis through the deregulation of important molecular functions. The gene discussed is PRMT1; the disease is breast carcinoma.